14/10/2014 - 15:09
NEWPORT BEACH, CALIF. – The approval of apremilast (Otezla) for the treatment of moderate to severe plaque psoriasis will make a significant impact on patient care, Dr. Alan Menter of Baylor...
Field of Interest: Dermatology
Categories:
News Feed: Internal Medicine News - Dermatology